19-44513188-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001102597.3(CEACAM20):āc.1411A>Cā(p.Ile471Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000806 in 1,612,318 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 9/12 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001102597.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CEACAM20 | NM_001102597.3 | c.1411A>C | p.Ile471Leu | missense_variant | 7/12 | ENST00000614924.5 | NP_001096067.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CEACAM20 | ENST00000614924.5 | c.1411A>C | p.Ile471Leu | missense_variant | 7/12 | 1 | NM_001102597.3 | ENSP00000481937 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152016Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000362 AC: 9AN: 248830Hom.: 0 AF XY: 0.0000593 AC XY: 8AN XY: 135006
GnomAD4 exome AF: 0.0000829 AC: 121AN: 1460184Hom.: 0 Cov.: 29 AF XY: 0.0000840 AC XY: 61AN XY: 726448
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152134Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74360
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 26, 2024 | The c.1411A>C (p.I471L) alteration is located in exon 7 (coding exon 7) of the CEACAM20 gene. This alteration results from a A to C substitution at nucleotide position 1411, causing the isoleucine (I) at amino acid position 471 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at